Browse > Article
http://dx.doi.org/10.15324/kjcls.2021.53.4.342

The Interaction of High Sensitivity C-Reactive Protein and Uric Acid on Obesity in Koreans: Based on the Seventh Korea National Health and Nutrition Examination Survey (KNHANES VII, 2016~2018)  

Pyo, Sang Shin (Department of Biomedical Laboratory Science, Jungwon University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.53, no.4, 2021 , pp. 342-352 More about this Journal
Abstract
We used data from the 7th Korea National Health and Nutrition Examination Survey (KNHANES) (2016~2018) to investigate an association between high sensitivity C-reactive protein (hsCRP) and uric acid in the obese. Obesity was defined as a body mass index (BMI) of 25 kg/m2 or more, severe obesity as a BMI of 30 kg/m2 or more, and morbid obesity as a BMI of 35 kg/m2 or more. In the complex samples multiple logistic regression, despite adjustment by adding major risk factors, the odds ratio (OR) for obesity was higher in the group with high levels of both, hsCRP and uric acid than the reference group at all stages (obesity, OR 1.89, P<0.001 vs. severe obesity, OR 5.04, P<0.001 vs. morbid obesity, OR 8.20, P<0.001). The association between hsCRP and uric acid in obese patients increased from 1.89 to 8.20 as the obesity level increased, suggesting that participants with increased BMI were significantly affected by hsCRP and uric acid. Moreover, the interaction between hsCRP and uric acid was statistically significant even in the model corrected for major confounding factors (P for interaction=0.009).
Keywords
High sensitivity C-reactive protein; Interaction effect; Obesity; Uric acid;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015;23:512-518. https://doi.org/10.1002/oby.21003   DOI
2 Kim BY, Kang SM, Kang JH, Kang SY, Kim KK, Kim KB, et al. 2020 Korean society for the study of obesity guidelines for the management of obesity in Korea. JOMES. 2021;30:81-92. https://doi.org/10.7570/jomes21022   DOI
3 Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem. Curr Obes Rep. 2015;4:363-370. https://doi.org/10.1007/s13679-015-0169-4   DOI
4 McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, et al. Differentiation between obesity and insulin resistance in the association with c-reactive protein. Circulation. 2002;106:2908-2912. https://doi.org/10.1161/01.cir.0000041046.32962.86   DOI
5 Dayal D, Jain H, Attri SV, Bharti B, Bhalla AK. Relationship of high sensitivity c-reactive protein levels to anthropometric and other metabolic parameters in indian children with simple overweight and obesity. J Clin Diagn Res. 2014;8:PC05-PC08. https://doi.org/10.7860/JCDR/2014/8191.4685   DOI
6 Agnoletti D, Cicero AFG, Borghi C. The impact of uric acid and hyperuricemia on cardiovascular and renal systems. Cardiol Clin. 2021;39:365-376. https://doi.org/10.1016/j.ccl.2021.04.009   DOI
7 Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen Michael D, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metabolism. 2013;17:644-656. https://doi.org/10.1016/j.cmet.2013.03.008   DOI
8 Johnson RJ. Why focus on uric acid? Curr Med Res Opin. 2015;31:3-7. https://doi.org/10.1185/03007995.2015.1087979   DOI
9 Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, et al. Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med. 2006;209:257-262. https://doi.org/10.1620/tjem.209.257   DOI
10 Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2008;94:206-218. https://doi.org/10.1016/j.physbeh.2007.10.010   DOI
11 Sah SK, Khatiwada S, Pandey S, Kc R, Das BK, Baral N, et al. Association of high-sensitivity c-reactive protein and uric acid with the metabolic syndrome components. Springerplus. 2016;5:269. https://doi.org/10.1186/s40064-016-1933-y   DOI
12 Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean society for the study of obesity guideline for the management of obesity in korea. J Obes Metab Syndr. 2019;28:40-45. https://doi.org/10.7570/jomes.2019.28.1.40   DOI
13 Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on bangladeshi adults. PLoS One. 2018;13:e0206850. https://doi.org/10.1371/journal.pone.0206850   DOI
14 Chen C, Lu JM, Yao Q. Hyperuricemia-related diseases and xanthine oxidoreductase (xor) inhibitors: an overview. Med Sci Monit. 2016;22:2501-2512. https://doi.org/10.12659/msm.899852   DOI
15 Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease. Circulation. 2003;107:499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45   DOI
16 Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-237. https://doi.org/10.1242/dmm.001180   DOI
17 Oh K, Kim Y, Kweon S, Kim S, Yun S, Park S, et al. Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions. Epidemiol Health. 2021;43:e2021025. https://doi.org/10.4178/epih.e2021025   DOI
18 Lu J, Bai Z, Chen Y, Li Y, Tang M, Wang N, et al. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis. Rheumatology (Oxford). 2021;60:3628-3634. https://doi.org/10.1093/rheumatology/keaa822   DOI
19 Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012;33:144-151. https://doi.org/10.4082/kjfm.2012.33.3.144   DOI
20 Garrett SL, Pina-Thomas DM, Peterson KA, Benton MJ. Tracking physical activity in baccalaureate nursing students in the united states prior to graduation: a longitudinal study. Nurse Educ Today. 2019;80:28-33. https://doi.org/10.1016/j.nedt.2019.05.038   DOI
21 Shirasawa T, Ochiai H, Yoshimoto T, Nagahama S, Watanabe A, Yoshida R, et al. Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in japan. BMC Endocrine Disorders. 2020;20:2. https://doi.org/10.1186/s12902-019-0481-1   DOI
22 Zeng J, Lawrence WR, Yang J, Tian J, Li C, Lian W, et al. Association between serum uric acid and obesity in chinese adults: a 9-year longitudinal data analysis. BMJ Open. 2021;11:041919. https://doi.org/10.1136/bmjopen-2020-041919   DOI
23 Keenan T, Blaha MJ, Nasir K, Silverman MG, Tota-Maharaj R, Carvalho JA, et al. Relation of uric acid to serum levels of high-sensitivity c-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol. 2012;110:1787-1792. https://doi.org/10.1016/j.amjcard.2012.08.012   DOI
24 Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288:27138-27149. https://doi.org/10.1074/jbc.M113.485094   DOI
25 Leon-Pedroza JI, Escobedo G, Gonzalez-Chavez A. Relationship of hyperuricemia with low density lipoprotein, liver function tests and markers of systemic inflammation in patients with morbid obesity. Gac Med Mex. 2017;153:S42-S50. https://doi.org/10.24875/gmm.17000006   DOI
26 Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest. 2003;111:1805-1812. https://doi.org/10.1172/JCI18921   DOI
27 Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine. 2013;44:132-139. https://doi.org/10.1007/s12020-013-9912-3   DOI
28 Alberts A, Klingberg A, Wessig AK, Combes C, Witte T, Brand K, et al. C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1. Sci Rep. 2020;10:6391. https://doi.org/10.1038/s41598-020-63318-8   DOI
29 Lautenbach A, Stoll F, Mann O, Busch P, Huber TB, Kielstein H, et al. Long-term improvement of chronic low-grade inflammation after bariatric surgery. Obesity Surgery. 2021;31:2913-2920. https://doi.org/10.1007/s11695-021-05315-y   DOI
30 Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62:3307-3315. https://doi.org/10.2337/db12-1814   DOI